GLP-1 use linked to improved survival in patients with cancer

Darovasertib plus crizotinib improves outcomes in HLA-A2–negative metastatic uveal melanoma

Early-onset gastrointestinal cancers show more advanced disease and wider racial survival gaps

Xaluritamig plus abiraterone shows promising anti-tumour activity with manageable safety in chemotherapy-naïve mCRPC

Tarlatamab improves brain metastases control and survival compared to chemo in SCLC

Mobile app-based symptom monitoring helps maintain quality of life in advanced cancer

Aspirin use linked to improved survival in endometrial cancer

miR371 shows promise as a surveillance biomarker for relapse in early-stage germ cell tumours

Implanted tile-based radiation shows promise compared with stereotactic radiotherapy for brain metastases

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Lorlatinib delivers 7-year progression-free survival and durable brain control in ALK+ NSCLC

Low-dose pembrolizumab plus chemotherapy improves survival and expands access in advanced NSCLC